Association of the C-Reactive Protein-Triglyceride-Glucose Index with Stroke-Heart Syndrome and Clinical Prognosis in Patients Undergoing Endovascular Treatment
Related Experiment Videos
Wenjie Chen1, Xuesong Bai2, Tao Wang2
1Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Insights
The C-reactive protein-triglyceride-glucose index (CTI) predicts cardiac injury and poor outcomes in acute ischemic stroke (AIS) patients. This simple index helps identify high-risk individuals for stroke-heart syndrome after AIS.
Area of Science:
- Cardiology
- Neurology
- Biomarkers
Background:
- Stroke-heart syndrome (SHS), including acute myocardial injury, is a severe complication of acute ischemic stroke (AIS).
- The C-reactive protein-triglyceride-glucose index (CTI) combines inflammatory and metabolic markers.
- The predictive value of CTI for cardiac complications post-AIS is unknown.
Purpose of the Study:
- To investigate if the CTI can predict cardiac injury patterns in AIS patients.
- To determine if CTI predicts 90-day clinical outcomes, including functional status and mortality, in AIS patients.
Main Methods:
- A retrospective cohort study of 493 AIS patients undergoing endovascular treatment (EVT) at two centers.
- Cardiac troponin I (cTnI) trajectories were categorized into no injury, non-dynamic elevation, and dynamic elevation.
- Primary endpoint: poor functional status (modified Rankin Scale [mRS] 3-6) at 90 days. Secondary endpoint: 90-day all-cause death.
Main Results:
- Higher baseline CTI correlated with increased likelihood of dynamic troponin elevation (aOR=1.56).
- Dynamic troponin elevation was linked to significantly worse outcomes compared to no injury.
- Elevated CTI independently predicted poor 90-day functional outcome (Q4: aOR=3.04) and mortality (Q4: aOR=2.82).
Conclusions:
- The CTI serves as a predictor of stroke-heart syndrome (SHS) in AIS patients treated with EVT.
- The CTI is associated with adverse 90-day clinical outcomes.
- This easily calculated CTI index can aid in identifying AIS patients at higher risk for cardiac complications.
Background:
Stroke-heart syndrome (SHS), particularly acute myocardial injury, is a critical complication following acute ischemic stroke (AIS). The C-reactive protein-triglyceride-glucose index (CTI) integrates inflammatory and metabolic parameters but remains unexplored in the context of post-stroke cardiac complications. This study investigated whether CTI predicts cardiac injury patterns and 90-day clinical outcomes in AIS patients.
Methods:
A two-center retrospective cohort study was conducted in AIS patients undergoing endovascular treatment (EVT). Cardiac troponin I (cTnI) trajectories were classified into: no injury, non-dynamic elevation, and dynamic elevation. The primary endpoint was poor functional status at 90 days (modified Rankin Scale [mRS] 3-6); the secondary endpoint was 90-day all-cause death.
Results:
Among 493 individuals (median age 69 years, 42% female), higher baseline CTI was associated with a greater likelihood of dynamic troponin elevation (adjusted odds ratio [aOR] per 1-unit increase = 1.56 (1.26-1.94); p < 0.001). Patients with dynamic elevation had significantly worse outcomes compared to those with no injury. Elevated CTI was an independent predictor of 90-day poor functional outcome (Q4: aOR = 3.04 (1.53-6.05); p < 0.001) and mortality (Q4: aOR = 2.82 (1.33-6.00); p = 0.007).
Conclusions:
In EVT-treated AIS patients, the CTI is a predictor of SHS and adverse 90-day outcomes. This easily calculable index may help identify individuals at higher risk of cardiac complications after AIS.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies